drugset / Trial / NCT00475657

Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer

NCT00475657 ↗

Phase 2 Terminated 5 enrolled Eli Lilly and Company
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if cisplatin and pemetrexed are effective in the treatment of patients with Small Cell Lung Cancer, extended disease.

Timeline

Start
2007-10
Primary completion
2008-04
Completion
2008-04

Outcome

Outcome not reported

Stopped: “Terminated due to lack of efficacy”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 Intravenous
Subject Pemetrexed Small molecule 500 mg/m2 Intravenous